Glycosyn

Apr 26, 2023

Global Human Milk Oligosaccharides (HMO) Market – By Application Based on application, the global Human Milk Oligosaccharides (HMO) market is segmented into infant formula, functional food & beverages, food supplements, health ingredients, and others. The infant formula segment accounts for the highest market share. These HMO supplements shield newborns against infection. Additionally, it helps gut health maintenance, protects them from prebiotic effects, and boosts cognition. Therefore, most infant formula-making food companies add this component into their products, due to which its demand is gaining traction in the market. Please Visit the Press Release: https://www.blueweaveconsulting.com/press-release/global-human-milk-oligosaccharides-hmo-market-size-booming-more-than-4x-at-robust-cagr-of-23-during-2023-2029 Impact of COVID-19 on Global Human Milk Oligosaccharides (HMO) Market The market for Human Milk Oligosaccharides (HMO) was significantly impacted by the COVID-19 pandemic. Due to panic buying for at-home consumption during the early stages of the pandemic, the demand for HMOs soared during the lockdown. Because HMOs operate as an immunity booster, their sales increased during the pandemic as a result. However, restrictions on production activities and a shortage of labor also created a huge demand and supply gap that impacted the market revenue negatively in the later period of the COVID-19 outbreak. But it is estimated that the market will overall gain new opportunities owing to the rising health consciousness among consumers. Competitive Landscape Major players operating in the global Human Milk Oligosaccharides (HMO) market include Abbott Laboratories, FrieslandCampina Domo, DuPont Nutrition & Health, Jennewein Biotechnologie GmbH, Glycom A/S, Nestle S.A., Inbiose NV, ZuChem Inc., InnoBio Ltd., Elicityl SA, TCI Chemicals (India) Pvt. Ltd., Medolac Laboratories, Glycosyn LLC, Glycosyn-Stanford JV LLC, and ProZomix Limited. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches. The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Human Milk Oligosaccharides (HMO) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Human Milk Oligosaccharides (HMO) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market. Recent Developments In December 2022 – Kirin, a Japan-based integrated beverages company, announced the commencement of the first human milk oligosaccharides (HMO) production plant in Rayong Province, Thailand. In December 2022 – FrieslandCampina, a Netherlands-based multinational dairy cooperative, secured 2’-fucosyllactose approval in Australia and New Zealand for use in infant milk formula. Scope of the Report